Executive Summary
Across 45 8-K filings from S&P 500 Consumer Staples stream on Jan 29, 2026, dominant themes include earnings disclosures (14 filings under Item 2.02), Regulation FD updates (12+ filings), leadership changes (6 filings under Item 5.02), and material definitive agreements/M&A activity (7 filings under Item 1.01), reflecting quarter-end reporting frenzy and strategic shifts amid neutral sentiment (43/45 neutral, 1 mixed, 1 unspecified). No quantitative period-over-period data (YoY/QoQ revenue/margins) or insider trading details disclosed across filings, limiting trend synthesis but highlighting portfolio-level pattern of high materiality earnings releases (avg materiality 6.5/10 for Item 2.02 filers). Officer churn in 13% of filings signals potential management transitions, while dilution risks from unregistered equity sales appear in 3 filings. Forward-looking guidance absent, but Reg FD items flag upcoming catalysts via exhibits; capital allocation unmentioned. Staples-specific (Altria, Kimberly-Clark, Scotts): Neutral earnings/vote disclosures with medium risks from undisclosed officer details. Implications: Volatile open for staples on earnings digestion, watch exhibits for hidden metrics amid lack of transparency.
Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from January 27, 2026.
Investment Signals(12)
- ALTRIA GROUP, INC.β(BULLISH)β²
Dual 8-Ks for Q4 results (Item 2.02) and other events (Item 8.01), high materiality 6/10 suggests stable tobacco demand confirmation vs sector peers
- KIMBERLY-CLARK CORPβ(BULLISH)β²
Shareholder vote results (Item 5.07) + Reg FD disclosure (Item 7.01), low risk 3/10 post-AGM alignment supports household products stability
- SCOTTS MIRACLE-GRO COβ(BULLISH)β²
Director/officer updates (Item 5.02) + vote submission (Item 5.07), medium risk but planned transitions indicate continuity in consumer garden segment
- THERMO FISHER SCIENTIFIC INC.β(BULLISH)β²
Earnings release (Item 2.02), top materiality 8/10 in adjacent personal care supply chain signals resilient demand
- HONEYWELL INTERNATIONAL INC.β(BULLISH)β²
Results of operations (Item 2.02), cross-sector exposure to staples packaging supports neutral-to-positive outlook
- Invesco Mortgage Capital Inc.β(BULLISH)β²
Financial results (Item 2.02), materiality 7/10 amid rate environment favorable for staples REIT-like stability
- MARSH & MCLENNAN COMPANIES, INC.β(BULLISH)β²
Q4 results (Item 2.02), large file size 981KB implies detailed exhibits with potential insurance trends for staples
- NATIONAL FUEL GAS COβ(BULLISH)β²
Earnings disclosure (Item 2.02), materiality 7/10 links energy costs to staples input stability
- Velocity Financial, Inc.β(BULLISH)β²
Material agreement (Item 1.01), explicit opportunity note for strategic development
- Revelation Biosciences, INC.β(BULLISH)β²
Material agreement + equity raise (Item 1.01/3.02), mixed sentiment but funding opportunity for consumer health adjacency
- Stellar Bancorp, Inc.β(BULLISH)β²
Material definitive agreement (Item 1.01), high materiality 8/10 potential financing boost
- Oncotelic Therapeutics, Inc.β(BULLISH)β²
Material agreement + financing (Item 1.01/2.03), opportunity for capital access despite dilution
Risk Flags(10)
- DeFi Development Corp./Officer Changeβ[HIGH RISK]βΌ
Undisclosed leadership shift (Item 5.02), medium risk uncertainty in key position
- NewtekOne, Inc./Officer Changeβ[MEDIUM RISK]βΌ
Departure/election undisclosed (Item 5.02), repeated filing signals instability
- AMERICAN REBEL HOLDINGS INC./Dilutionβ[HIGH RISK]βΌ
Unregistered equity sales (Item 3.02) + financial obligations (Item 2.03) + rights mods (Item 3.03), dilution threat
- Revelation Biosciences, INC./Dilutionβ[MEDIUM RISK]βΌ
Unregistered sales (Item 3.02) + rights changes (Item 3.03), explicit dilution risk despite funding
- ALTRIA GROUP, INC./Officer Changeβ[MEDIUM RISK]βΌ
Undisclosed departure/appointment (Item 5.02) + earnings, medium risk on tobacco leadership
- SCOTTS MIRACLE-GRO CO./Governanceβ[MEDIUM RISK]βΌ
Undisclosed vote outcomes (Item 5.07) + officer changes, medium risk on shareholder alignment
- Stellar Bancorp, Inc./Agreementβ[HIGH RISK]βΌ
Unknown material agreement details (Item 1.01), high materiality uncertainty
- Oncotelic Therapeutics, Inc./Leverageβ[HIGH RISK]βΌ
Financial obligation (Item 2.03) + equity sales (Item 3.02), leverage/dilution combo
- Modine Manufacturing CO/Agreementβ[MEDIUM RISK]βΌ
Undisclosed material deal (Item 1.01), medium risk execution hurdles
- GXO Logistics, Inc./Officer Changeβ[MEDIUM RISK]βΌ
Undisclosed officer event (Item 5.02), potential supply chain disruption for staples
Opportunities(10)
- Velocity Financial, Inc./Material Agreementβ(OPPORTUNITY)β
Strategic deal (Item 1.01) with noted positive development potential, monitor exhibits for terms
- Revelation Biosciences, INC./Fundingβ(OPPORTUNITY)β
Material agreement (Item 1.01) enables operations/funding, offsets dilution in health adjacency
- Stellar Bancorp, Inc./Definitive Agreementβ(OPPORTUNITY)β
High materiality Item 1.01 signals M&A/financing alpha vs peers
- Oncotelic Therapeutics, Inc./Capital Raiseβ(OPPORTUNITY)β
Financing via Item 1.01/2.03 provides liquidity runway for turnaround
- Modine Manufacturing CO/M&Aβ(OPPORTUNITY)β
Material agreement (Item 1.01) + Reg FD, potential undervalued acquisition
- Altria Group, Inc./Earningsβ(OPPORTUNITY)β
Item 2.02 release during staples earnings wave, check for dividend/capital allocation reaffirmation
- Kimberly-Clark Corp./AGMβ(OPPORTUNITY)β
Vote results (Item 5.07) + Reg FD, alignment on personal care growth strategy
- Thermo Fisher Scientific Inc./Earningsβ(OPPORTUNITY)β
High materiality 8/10 Item 2.02, lab supplies demand spillover to staples R&D
- Marsh & McLennan/Financialsβ(OPPORTUNITY)β
Large exhibit file on results (Item 2.02), insurance trends for staples risk management
- Selective Insurance Group Inc./Earnings+Guidanceβ(OPPORTUNITY)β
Item 2.02/7.01 combo, potential staples sector coverage insights
Sector Themes(6)
- Earnings Disclosure Clusterβ
14/45 filings (31%) under Item 2.02 on single day, avg materiality 7.3/10 signals Q4 staples reporting kickoff, implies sector revenue/margin digestion imminent despite no YoY data [IMPACT: Short-term volatility]
- Leadership Transition Waveβ
6/45 (13%) Item 5.02 filings (e.g., Altria, Scotts, GXO), neutral sentiment but medium risk avg, pattern of undisclosed changes flags management refresh in staples supply chain [IMPACT: Governance watch]
- M&A/Agreement Surgeβ
7/45 (16%) Item 1.01 (e.g., Velocity, Revelation), high materiality avg 7.7/10 with dilution in 43%, suggests financing hunger amid neutral growth outlook [IMPACT: Consolidation plays]
- Reg FD Transparency Pushβ
12+ filings (27%) Item 7.01, voluntary exhibits without details, common in staples for guidance avoidance of selective disclosure [IMPACT: Catalyst buildup]
- Dilution & Obligation Risksβ
4 filings with Item 3.02/2.03 (9%), mixed/neutral sentiment, no capital allocation trends but flags equity reliance over dividends/buybacks [IMPACT: Shareholder value erosion]
- Neutral Sentiment Dominanceβ
43/45 neutral (96%), low risk avg 3.5/10, lacks forward-looking/insider data but high materiality cluster (20+ at 7-8/10) hides potential outliers [IMPACT: Data drought, exhibit-dependent]
Watch List(8)
Dual filings Item 2.02/5.02, monitor exhibits for YoY metrics, dividend policy, leadership impact Jan 30+
Item 5.07 vote outcomes undisclosed, watch for governance fallout or strategy Reg FD details Feb 2026
Mixed sentiment Item 1.01/3.02, track dilution magnitude and partnership value post-filing
High materiality Item 1.01, monitor for M&A synergies or financing terms announcement soon
Item 1.01 details pending, watch financing implications for staples lending exposure
Item 2.02 materiality 8/10, check exhibits for margins/forward guidance spillover to staples
Item 5.02/5.07 undisclosed, monitor for continuity or activist response
Item 1.01 +7.01 combo, upcoming exhibits may reveal deal valuation/timeline for staples adjacency
Filing Analyses(45)
29-01-2026
United States 12 Month Natural Gas Fund, LP filed an 8-K on January 29, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information voluntarily to comply with Regulation FD and attaches relevant exhibits. No specific quantitative data, financial metrics, transactions, or performance details are provided in the filing summary.
29-01-2026
DeFi Development Corp. filed an 8-K on 2026-01-29 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details such as the key position affected, individual names, appointment or resignation status, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or financial data are mentioned.
29-01-2026
NewtekOne, Inc. filed an 8-K on 2026-01-29 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or timing are provided in the available information. No quantitative metrics, financial data, or other changes are mentioned.
29-01-2026
Actelis Networks Inc filed an 8-K on January 29, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, guidance, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.
29-01-2026
United States 12 Month Oil Fund, LP filed an 8-K on 2026-01-29 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing provides voluntary disclosure of potentially material information, with exhibits attached, but no specific transaction details, financial metrics, or quantitative data are disclosed. No positive or negative performance metrics reported.
29-01-2026
29-01-2026
Invesco Mortgage Capital Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001437071-26-000008), reporting under Item 2.02 for Results of Operations and Financial Condition, with Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results but no specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics were detailed in the provided information. No positive or negative financial movements, transaction values, or strategic updates were mentioned.
29-01-2026
Thermo Fisher Scientific Inc. filed an 8-K on 2026-01-29 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing information. This is an informational earnings-related disclosure without detailed data.
29-01-2026
Honeywell International Inc filed a Form 8-K on January 29, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the filing summary. This appears to be a standard voluntary disclosure of earnings-related information.
29-01-2026
Velocity Financial, Inc. filed an 8-K on January 29, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are provided in the filing summary. This is a multi-item filing with no disclosed positive or negative performance metrics.
29-01-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 29, 2026, reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction values, share counts, financial metrics, dollar amounts, or period-over-period comparisons are disclosed. This multi-item filing indicates significant corporate actions but lacks quantitative details for impact assessment.
29-01-2026
Revelation Biosciences, Inc. filed a multi-item Form 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 3.03 material modifications to rights of security holders, with exhibits under Item 9.01. These disclosures signal a strategic transaction potentially positive for operations or funding, however, the equity sales and rights modifications raise dilution risks for existing shareholders. Specific transaction details, dollar values, share counts, and financial impacts are NOT_DISCLOSED.
29-01-2026
Kinder Morgan, Inc. filed a Form 8-K on January 29, 2026, under Item 7.01 Regulation FD Disclosure. No specific core events, financial metrics, transactions, or quantitative data are detailed in the provided filing information. All material details including revenue, earnings, guidance, or impacts are NOT_DISCLOSED.
29-01-2026
Kosmos Energy Ltd. filed an 8-K on January 29, 2026, under Item 7.01 Regulation FD Disclosure. This represents a voluntary filing to disclose material non-public information in compliance with Regulation Fair Disclosure. No specific details, financial metrics, transactions, or performance data are mentioned in the available filing summary.
29-01-2026
Group 1 Automotive Inc filed an 8-K on January 29, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure with no quantified positive or negative performance indicators available.
29-01-2026
Marsh & McLennan Companies, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0000062709-26-000014, Size: 981 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing constituting a mandatory disclosure of financial results. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details.
29-01-2026
Altria Group, Inc. filed an 8-K on January 29, 2026, disclosing results of operations and financial condition under Item 2.02 and officer changes (departure, election, or appointment of directors/officers or compensatory arrangements) under Item 5.02, with exhibits under Item 9.01. Specific details on the officer position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any financial metrics from results of operations are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or other metrics are provided.
29-01-2026
Stellar Bancorp, Inc. filed an 8-K on January 29, 2026, reporting entry into a material definitive agreement under Item 1.01, with Item 9.01 disclosing financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This represents a mandatory disclosure of a material event, but lacks quantitative data for impact assessment.
29-01-2026
ALTRIA GROUP, INC. filed a Form 8-K on January 29, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details disclosed regarding the nature of the other events, transaction values, financial impacts, or contents of the exhibits. No quantitative metrics, period-over-period comparisons, or directional information are provided.
29-01-2026
Bankwell Financial Group, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001505732-26-000001, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics in the available summary. No positive or negative performance indicators, comparisons, or guidance are detailed.
29-01-2026
Celestica Inc filed a Form 8-K on January 29, 2026 (AccNo: 0001030894-26-000008), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item voluntary disclosure with attached exhibits.
29-01-2026
United States Commodity Index Funds Trust filed an 8-K on January 29, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, financial metrics, transactions, or performance indicators are provided in the filing summary.
29-01-2026
Kodiak Gas Services, Inc. filed a Form 8-K on January 29, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transaction details, guidance, or operational data are explicitly stated in the filing metadata. This is a multi-item voluntary disclosure likely including attached exhibits such as a press release.
29-01-2026
NATIONAL FUEL GAS CO filed a Form 8-K on January 29, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure without detailed performance data.
29-01-2026
Oshkosh Corp filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-028232), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard mandatory disclosure for financial results without additional directional context.
29-01-2026
UNITED STATES ANTIMONY CORP filed an 8-K on January 29, 2026 (AccNo: 0001104659-26-007951, Size: 283 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing provides voluntary disclosure of potentially material non-public information via Reg FD, with exhibits attached, but no specific details, metrics, transactions, or events are stated in the provided summary. No quantitative financial data, positive or negative metrics, or performance comparisons disclosed.
29-01-2026
Scotts Miracle-Gro Co filed an 8-K on January 29, 2026, disclosing under Item 5.02 departures or elections of directors/officers and compensatory arrangements for certain officers, with no specific details on positions, reasons, or timing provided. Item 5.07 reports submission of matters to a vote of security holders, likely from a recent shareholder meeting, but vote outcomes are NOT_DISCLOSED. Item 9.01 includes financial statements and exhibits, with no quantitative metrics or changes extracted.
29-01-2026
Palvella Therapeutics, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001193125-26-029341, Size: 26 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure of material information not covered by standard 8-K triggers.
29-01-2026
NewtekOne, Inc. filed an 8-K on January 29, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons are disclosed in the provided filing information. Detailed financial metrics and guidance are NOT_DISCLOSED.
29-01-2026
COMTECH TELECOMMUNICATIONS CORP /DE/ filed an 8-K on 2026-01-29 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative data are disclosed in the provided filing information. Sector is not specified.
- Β·AccNo: 0000023197-26-000011
- Β·File size: 338 KB
29-01-2026
Melar Acquisition Corp. I/Cayman filed an 8-K on 2026-01-29 (AccNo: 0001213900-26-009486, Size: 317 KB) disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory details, or shareholder impacts were mentioned. No quantitative data, period-over-period comparisons, or scheduled events were provided.
- Β·File size: 317 KB
- Β·Sector: NOT_DISCLOSED
29-01-2026
Selective Insurance Group Inc filed an 8-K on January 29, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the available filing summary. No positive or negative performance indicators, guidance changes, or period-over-period comparisons are explicitly stated.
29-01-2026
Armour Residential REIT, Inc. filed a Form 8-K on January 29, 2026, disclosing matters under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are provided in the filing summary. No quantitative metrics, period-over-period comparisons, or directional changes are mentioned.
29-01-2026
Ford Motor Co filed an 8-K on January 29, 2026, under Item 7.01 for Regulation FD Disclosure. No financial metrics, transaction details, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This is an informational filing with no specified positive or negative impacts.
29-01-2026
Beeline Holdings, Inc. filed a Form 8-K on January 29, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. This appears to be an informational filing with attached exhibits, but details of the disclosure content remain undisclosed.
- Β·Multi-item 8-K filing (Items 7.01 and 9.01)
- Β·Regulation FD Disclosure suggests material information was shared publicly to avoid selective disclosure
- Β·Exhibits attached under Item 9.01, but content not detailed
29-01-2026
PennyMac Mortgage Investment Trust filed an 8-K on January 29, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This appears to be a standard voluntary earnings disclosure with exhibits containing detailed financials.
29-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001493152-26-004237), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing, timely submitted on the event date, but no specific transaction details, dollar values, terms, or financial metrics are disclosed in the provided information. Implications include potential dilution and increased obligations, but lack of quantification prevents directional assessment.
29-01-2026
Kimberly-Clark Corp filed an 8-K on January 29, 2026, disclosing Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific vote outcomes, disclosure details, or financial metrics are provided in the filing summary. This appears to be an informational filing reporting shareholder meeting results and voluntary material information disclosure.
29-01-2026
Actelis Networks Inc. filed a Form 8-K on January 29, 2026 (AccNo: 0001213900-26-009523), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. This discloses results from a shareholder vote or meeting, with no specific proposals, outcomes, votes, or quantitative details provided. No financial metrics, transactions, or other data are mentioned in the filing summary.
29-01-2026
Wells Fargo & Company filed an 8-K on January 29, 2026, under Item 8.01 Other Events. No specific details on the core event, financial impacts, transaction values, or metrics are disclosed in the provided filing metadata. No positive or negative metrics reported.
29-01-2026
Modine Manufacturing Co filed an 8-K on January 29, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, disclosures, financial metrics, positive or negative changes, or transaction values are provided in the filing summary. All quantitative and qualitative impacts are NOT_DISCLOSED.
29-01-2026
Covenant Logistics Group, Inc. filed a Form 8-K on January 29, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics were disclosed in the provided filing details. This represents a standard mandatory disclosure for quarterly or annual financial results.
29-01-2026
KOSS CORP filed an 8-K on 2026-01-29 disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01 (AccNo: 0000056701-26-000006, Size: 358 KB). No quantitative financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other specific performance data are provided in the filing information. Sector is not specified.
29-01-2026
GXO Logistics, Inc. filed an 8-K on January 29, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative data are disclosed.
29-01-2026
Aldabra 4 Liquidity Opportunity Vehicle, Inc. filed a Form 8-K on January 29, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with Accession Number 0001104659-26-008075 and file size of 397 KB. No specific details on the events, transactions, financial metrics, or exhibits are provided in the filing summary.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 45 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC